{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:24:15Z","timestamp":1794439455379,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amepre.2026.108367","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:33:07Z","timestamp":1775665987000},"page":"108367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Florida's Opioid Prescribing Law Associated With Halt in Declining Opioid Fills Among New Users"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0433-4062","authenticated-orcid":false,"given":"Emma B.","family":"Dean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-2251","authenticated-orcid":false,"given":"Mallick","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1230-600X","authenticated-orcid":false,"given":"Daniel","family":"Kaliski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2026.108367_bib0001","unstructured":"Provisional drug overdose death counts. Drug overdose data. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Updated March 11, 2026. Accessed March 11, 2026."},{"key":"10.1016\/j.amepre.2026.108367_bib0002","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drugalcdep.2018.09.022","article-title":"Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review","volume":"194","author":"Davis","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.amepre.2026.108367_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain \u2014 United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.amepre.2026.108367_bib0004","series-title":"Oxford Research Encyclopedia of Economics and Finance","article-title":"Economic studies on the opioid crisis: costs, causes, and policy responses","author":"Maclean","year":"2021"},{"issue":"1","key":"10.1016\/j.amepre.2026.108367_bib0005","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12913-017-2354-5","article-title":"Evaluating the impact of prescription drug monitoring program implementation: a scoping review","volume":"17","author":"Finley","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.amepre.2026.108367_bib0006","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s12913-019-4642-8","article-title":"The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review","volume":"19","author":"Rhodes","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.amepre.2026.108367_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1257\/pol.20160094","article-title":"The effect of prescription drug monitoring programs on opioid utilization in Medicare","volume":"10","author":"Buchmueller","year":"2018","journal-title":"Am Econ J Econ Policy"},{"issue":"2","key":"10.1016\/j.amepre.2026.108367_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the U.S. opioid epidemic, 2007\u20132018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2026.108367_bib0009","series-title":"AMA 2021 overdose epidemic report","year":"2021"},{"issue":"1","key":"10.1016\/j.amepre.2026.108367_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMsa1514387","article-title":"State legal restrictions and prescription-opioid use among disabled adults","volume":"375","author":"Meara","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amepre.2026.108367_bib0011","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1162\/ajhe_a_00101","article-title":"Prescription drug monitoring programs: the role of asymmetric information on drug availability and abuse","volume":"4","author":"Meinhofer","year":"2018","journal-title":"Am J Health Econ"},{"issue":"1","key":"10.1016\/j.amepre.2026.108367_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/716462","article-title":"Policy-induced substitution to illicit drugs and implications for law enforcement activity","volume":"8","author":"Mallatt","year":"2022","journal-title":"Am J Health Econ"},{"issue":"3","key":"10.1016\/j.amepre.2026.108367_bib0013","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/soej.12481","article-title":"Prescription drug monitoring programs, opioid abuse, and crime","volume":"87","author":"Dave","year":"2021","journal-title":"South Econ J"},{"issue":"3","key":"10.1016\/j.amepre.2026.108367_bib0014","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s11606-019-05302-1","article-title":"Impact of a state opioid prescribing limit and electronic medical record alert on opioid prescriptions: a difference-in-differences analysis","volume":"35","author":"Lowenstein","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amepre.2026.108367_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2020.102397","article-title":"Can policy affect initiation of addictive substance use? Evidence from opioid prescribing","volume":"76","author":"Sacks","year":"2021","journal-title":"J Health Econ"},{"issue":"3","key":"10.1016\/j.amepre.2026.108367_bib0016","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/pm\/pnz159","article-title":"Opioid prescribing laws are not associated with short-term declines in prescription opioid distribution","volume":"21","author":"Davis","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.amepre.2026.108367_bib0017","unstructured":"Florida Health. 2019 PDMP annual report; Last updated 2020.https:\/\/www.floridahealth.gov\/statistics-and-data\/e-forcse\/laws-rules\/2019-pdmp-annual-report.pdf. Accessed January 1, 2025."},{"issue":"10","key":"10.1016\/j.amepre.2026.108367_bib0018","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida\u2019s prescription drug monitoring program and pill mill laws on opioid prescribing and use","volume":"175","author":"Rutkow","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.amepre.2026.108367_bib0019","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/pds.3553","article-title":"Reductions in prescription opioid diversion following recent legislative interventions in Florida","volume":"23","author":"Surratt","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amepre.2026.108367_bib0020","unstructured":"H. Johnson, L. Paulozzi, C. Porucznik, K. Mack, B. Herter and Hal Johnson, Consulting and Division of Disease Control and Health Promotion, Florida Department of Health. Decline in drug overdose deaths after state policy changes - Florida, 2010-2012, MMWR Morb Mortal Wkly Rep., 63 (26), 2014, 569\u2013574. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4584904\/. Accessed September 1, 2025."},{"issue":"3","key":"10.1016\/j.amepre.2026.108367_bib0021","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jamasurg.2019.4913","article-title":"Association of Florida House bill 21 with postoperative opioid prescribing for acute pain at a single institution","volume":"155","author":"Porter","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.amepre.2026.108367_bib0022","article-title":"The impact of the Florida law hb21 on opioid prescribing patterns after spine surgery","volume":"14","author":"Geller","year":"2023","journal-title":"N Am Spine Soc J"},{"issue":"2","key":"10.1016\/j.amepre.2026.108367_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0234","article-title":"Changes in opioid use after Florida\u2019s restriction law for acute pain prescriptions","volume":"3","author":"Hincapie-Castillo","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.amepre.2026.108367_bib0024","doi-asserted-by":"crossref","first-page":"417","DOI":"10.36076\/ppj.2021.24.417","article-title":"Chronic opioid therapy utilization following an acute pain prescription supply restriction law: an interrupted time series analysis","volume":"24","author":"Shen","year":"2021","journal-title":"Pain Physician"},{"issue":"6","key":"10.1016\/j.amepre.2026.108367_bib0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MLR.0000000000001719","article-title":"Prescription patterns of adjuvant pain medications following an opioid supply restriction law: an interrupted time series analysis","volume":"60","author":"Shen","year":"2022","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.amepre.2026.108367_bib0026","first-page":"779","article-title":"Changes in Schedule II oral opioid volume dispensed in a private health plan following Florida\u2019s Acute Pain Opioid Restriction Law","volume":"27","author":"Oueini","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"10.1016\/j.amepre.2026.108367_bib0027","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1377\/hlthaff.2019.00103","article-title":"Prescription drug monitoring program mandates: impact on opioid prescribing and related hospital use","volume":"38","author":"Wen","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"10.1016\/j.amepre.2026.108367_bib0028","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/MLR.0000000000001411","article-title":"State opioid limits and volume of opioid prescriptions received by Medicaid patients","volume":"58","author":"Zhang","year":"2020","journal-title":"Med Care"},{"issue":"12","key":"10.1016\/j.amepre.2026.108367_bib0029","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jpain.2019.05.006","article-title":"Development and assessment of a crosswalk between ICD-9-CM and ICD-10-CM to identify patients with common pain conditions","volume":"20","author":"Mayhew","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.amepre.2026.108367_bib0030","series-title":"Measures and CDS for safer opioid prescribing: a literature review","year":"2019"},{"issue":"1","key":"10.1016\/j.amepre.2026.108367_bib0031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/pm\/pnx304","article-title":"Implementing electronic health record default settings to reduce opioid overprescribing: a pilot study","volume":"20","author":"Zivin","year":"2019","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.amepre.2026.108367_bib0032","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/AJP.0000000000000571","article-title":"Associations between early care decisions and the risk for long-term opioid use for patients with low back pain with a new physician consultation and initiation of opioid therapy","volume":"34","author":"Fritz","year":"2018","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.amepre.2026.108367_bib0033","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.amepre.2026.108367_bib0034","series-title":"R: a language and environment for statistical computing","year":"2019"},{"key":"10.1016\/j.amepre.2026.108367_bib0035","series-title":"Stata statistical software: Release 18","year":"2023"},{"issue":"9596","key":"10.1016\/j.amepre.2026.108367_bib0036","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.amepre.2026.108367_bib0037","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1093\/qje\/qjaf037","article-title":"What drives risky prescription opioid use? Evidence from migration","volume":"140","author":"Finkelstein","year":"2025","journal-title":"Q J Econ"},{"key":"10.1016\/j.amepre.2026.108367_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpubeco.2023.104980","article-title":"Dangerous prescribing and healthcare fragmentation: evidence from opioids","volume":"225","author":"Ericson","year":"2023","journal-title":"J Public Econ"},{"issue":"6","key":"10.1016\/j.amepre.2026.108367_bib0039","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.amepre.2026.108367_bib0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3365","article-title":"Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review","volume":"2","author":"Klimas","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2026.108367_bib0041","unstructured":"Evaluating the utility of emergency department encounter data and examining social determinants of emergency department utilization in Utah. Census.gov. https:\/\/www.census.gov\/library\/working-papers\/2021\/demo\/SEHSD-WP2021-07.html. Updated March 31, 2023. Accessed March 6, 2025."},{"issue":"4","key":"10.1016\/j.amepre.2026.108367_bib0042","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.annemergmed.2016.06.027","article-title":"Relationship between continuity of ambulatory care and risk of emergency department episodes among older adults","volume":"69","author":"Nyweide","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.amepre.2026.108367_bib0043","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/pds.4254","article-title":"Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program","volume":"26","author":"Hartung","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amepre.2026.108367_bib0044","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-med-011817-044739","article-title":"Use and misuse of opioids in chronic pain","volume":"69","author":"Volkow","year":"2018","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.amepre.2026.108367_bib0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajim.23683","article-title":"Association between pre-injury opioid use and opioid use patterns after a work injury","volume":"68","author":"Fulton-Kehoe","year":"2025","journal-title":"Am J Ind Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379726001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379726001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:01:25Z","timestamp":1794438085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379726001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0749379726001108"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2026.108367","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Florida's Opioid Prescribing Law Associated With Halt in Declining Opioid Fills Among New Users","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2026.108367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108367"}}